Summary
The role of bile acids in pharmacotherapy is reviewed in this article. The therapeutic use of bile has been recognized since ancient times. Previously bile acids were the standard treatment for gallstones where chenodeoxycholic acid and ursodeoxycholic acid were effective in promoting the dissolution of cholesterol gallstones. Today their therapeutic role looks set to expand enormously. Bile acids as absorption promoters have the potential to aid intestinal, buccal, transdermal, ocular, nasal, rectal and pulmonary absorption of various drugs at concentrations that are non-toxic. Keto derivatives of cholic acid, such as 3a, 7a, dihydroxy-12-keto-5a-cholic acid (sodium salt and methyl ester) are potential modifiers of blood-brain barrier transport and have been shown to promote quinine up-take, enhance the analgesic effect of morphine and prolong the sleeping time induced by pentobarbital. They have also been shown to be hypoglycaemic. Bile acids as therapeutic agents have the potential to produce beneficial effects in sexually transmitted diseases, primary biliary cirrhosis, primary sclerosing cholangitis, gallstones, digestive tract diseases, cystic fibrosis, cancer and diabetes.
Similar content being viewed by others
References
Laurence D. (ed.) (1998):A Dictionary of Pharmacology and Allied Topics. 2nd edition, Elsevier, The Netherlands.
Hsieh D. (ed.) (1994):Drug Permeation Enhancement Theory and Applications. Marcel Dekker Inc, New York.
Sayani A.P., Chien Y.W. (1996):Critical Reviews in Therapeu tic Drug Carrier Systems 13, 85.
Trauner M., Boyer J. (2003):Physiol. Rev. 83, 633.
O’Reilly J., Corrigan O., O’Driscoll C. (1994):Int. J. Pharm. 109, 147.
Mesiha M., Ponnapula S., Plakogiannis F. (2002):Int. J. Pharm. 249, 1.
Michael S., Thole M., Dillmann R., Fahr A., Drewe J., Fricker G. (2000):Eur. J. Pharm. Sci. 10, 133.
Mrestani Y., Bretschneider B., Harti A., Neubert R. (2003):J. Pharm. Pharmacol. 55, 1601.
Newton J.M., Rowley G., Tornblom J.V. (1971):J. Pharm. Pharmacol. 23, 156S.
Borras-Blasco J., Diez-Sales O., Lopez A., Herraez-Dominguez M. (2004):Int. J. Pharm., 269.
Hye J.A., Kyoung M.K., Kim C.-K. (1998):Drug Devel. Indust. Pharm. 24, 697.
Martin-Algarra R.V., Pascual-Costa R.M., Merino M., Casabo V.G. (1994):Pharm. Res. 11, 1042.
Senel S., Hoogstraate F., Spies J.C., Verhoef H.E., Junginger H.E., Bodde H.E. (1993):Eur. J. Morphol. 31, 35.
Nakane S., Kakumoto M., Yukimatsu K., Chien Y.W. (1996):Pharmac. Devel. Technol. 1, 251.
Deneer V., Drese G., Roemele P., Verhoef J., Lie-A-Huen L., Kingma J., Brouwers J., Junginger H. (2002):Int. J. Pharm. 241, 127.
Gandhi R., Robinson J.R. (1985):Int. J. Pharmacol. 85, 129.
Lee V.H.L., Yamamoto A., Kompella U.B. (1991):Crit. Rev. Ther. Drug Carrier Systems 8, 91.
Hofer C., Härtung R., Göbel R., Deering P., Lehmer A., Breul J. (2000):World J. Surg. 24, 1187.
Cevc G., Blume G., Schatzlein A., Gebauer D., Paul A. (1996):Advanced Drug Delivery Systems 18, 349.
Paul A., Cevc G. (1995):Vaccine Res. 4, 145.
Guo J., Ping Q., Huang L.J. (1999):China Pharm. Unv. 30, 184–186.
Cevc G., Blume G. (1992):Biochem. Biophys. Acta 1104, 226.
Nokhodchi A., Shokri J., Dashbolaghi A., Hassan-Zadeh D., Ghafourian T., Barzegar-Jalali M. (2003):Int. J. Pharm. 250, 359.
Shokri J., Nokhodchi A., Dashbolaghi A., Hassan-Zadeh D., Ghafourian T., Barzegar-Jalali M. (2001):Int. J. Pharm. 228, 99.
Yamamoto A., Luo A., Dodda-Kashi S., Lee V. (1989):J. Pharmacol. Exp. Ther. 249, 249.
Longenecker J., Moses A., Flier J., Silver R., Carey M., Dubovi (1987):J. Pharm. Sci. 76, 351.
Samiy N., D’Amico D.J. (1996):Int. Ophthalmol. Clin. 36, 147.
Tabbara K.F., Hyndiuk R.A. (eds) (1996):Infections of the Eye. 2nd Edition, Little, Brown, Boston.
Souri E.N., Green W.R. (1974):Am. J. Ophthalmol. 78, 77.
Doft B.H., Weiskopf J., Nilsson-Ehle I., Wingard L.B. (1985):Ophthalmology 92, 1601.
Tremblay C., Barza M., Szoka F., Lahav M., Baum J. (1985):Invest. Ophthalmol. Vis. Sci. 26, 711.
Cannon J.P., Hscella R., Pattharachayakul S., Garey K.W., De Alba F., Piscitelli S., Edward D.P., Danziger L.H. (2003):Invest. Ophthalmol. Vis. Sci. 44, 2112.
Shao Z., Mitra A.K. (1992):Pharm. Res. 9, 1184.
Gordon G.S., Moses A.C., Silver R.D., Flier J.S., Carey M.C. (1985):Proc. Natl. Acad. Sci. 82, 7419.
Junginger H.E. (1992):Drug Targeting and Delivery: Concepts in dosage form design. Ellis Horwood Limited, England.
Hersey S.J, Jackson R.T. (1987):J. Pharm. Sci. 76, 877.
Ilium L., Fischer A.N., Jabbal-Gill I., Davis S.S. (2001):Int. J. Pharm. 222, 109.
Bjork E., Bjurstron S., Edman P. (1991):Int. J. Pharm. 75, 73.
Hirai S., Ikenaga T., Matsuzawa T. (1978):Diabetes 27, 296.
Moses A.C., Gordon G.S., Carey M.C., Flier J.S. (1983):Diabetes 32, 1041.
Alberts B., Bray D., Lewis J., Raff M., Roberts K., Watson J. (eds) (1983):Molecular Biology of the Cell. Garland, New York.
Donovan M.D., Flynn G.L., Amidon G.L. (1990):Pharm Res., 7, 808.
Aungst B.J., Rogers N.J., Shefter E. (1988):J. Pharmacol. Exp. Ther. 244, 23.
Agu R.U., Ugwoke M.I., Armand M., Kinget R., Verbeke N. (2001):Respir. Res. 2, 198.
Heinemann L., KIoppoth W., Rave K., Hompesch B., Linkeschowa R., Heise T. (2000):Diabetes Care, 23, 1343.
Fukuda Y., Tsuji T., Fujita T., Yamamoto A., Muranishi S. (1995):Biol. Pharm. Bull. 18, 891.
Widmaier E., Raff H., Strang K. (eds) (2004):Vander, Sherman and Luciano’s Human Physiology — The Mechanisms of Body Function. 9th Edition, McGraw-Hill, Boston.
Yamamoto A., Okumura S., Fukuda Y., Fukui M., Takahashi K., Muranishi S. (1997):J. Pharm. Sci. 86, 1144.
Monta T., Yamamoto A., Takakura Y., Hashida M., Sezaki H. (1994):Pharm. Res. 11, 909.
Kaneko T., Sato T., Katsuya H., Miyauchi Y. (1990):Crit. Care Med. 18, 77, 1990.
Watanaube A., Fujuwara M., S. Tominaga, Nagashima H. (1987):Hiroshima J. Med. Sci. 36, 257.
Spiegelman M.K., Zappulla R.A., Malis L.I., Holland J.F., Goldsmith S.J., Goldberg J.D. (1983):Neurosurgery 12, 606.
Mikov M., Kevresan S., Kuhajda K., Jakovljevic V., Vasovic V. (2004):Polish J. Pharmacol. 56, 367.
Lloyd G., Sutton P.M., Atkinson T. (1988):Lancet 25, 1418.
Fenner F., White D.O. (1970):Med. Virol. Academic Press.
Herold B.C., Kirkpatrick R., Marcellino D., Travelstead A., Pilipenko K., Krasa H., Bremer J., Dong L.J., Cooper M.D. (1999):Antimicrob. Agents Chemother. 43, 745.
Kowdley K.V. (2000):Am. J. Med. 108, 481.
Poupon R.E., Balkau B., Eschwege E., Poupon R. (1991):N. Engl. J. Med. 324, 1548.
Poupon R.E., Lindor KD., Cauch-Dudek K., Dickson E.R., Poupon R., Heathcote E.J. (1997):Gastroenterology 113, 884.
Paumgartner G., Beuers U. (2002):Hepatology 36, 525.
Beuers U., Spengler U., Kruis W., Aydemir U., Wiebecke B., Heldwein W., Weinzier L.M., Pape G.R., Sauerbruch T., Paumgartner G. (1992):Hepatology 16, 707.
Ransohoff D.F., Gracie W.A. (1993):Annals Intern. Med. 119, 607.
Danzinger R.G., Hofmann A.F., Schoemfield L.J., Thistle J.L. (1972):N. Engl. J. Med. 286, 1.
Makino I., Hashimoto H., Shinozaki K., Nakagawa S. (1975):Jpn. J. Gastroenterol. 72, 690.
Salen G., Nicolau G., Shefer S. (1973):Clin. Res. 21, 523.
Coyne M.J., Bonorris G.G., Goldstein L.J. (1976):J. Lab. Clin. Med. 87, 281.
Angelin B., Ewerth S., Einarsson K. (1983):J. Upid Res. 24, 461, 1983.
W.G. Hardison, S.M. Grundy,Gastroenterology,87, 130.
Maudgal D.P., Noithfield T.C. (1991):Drugs 41, 185.
Bell G.D., Dowling R.H., Whitney B., Sutor D.J. (1975):Gut 16, 359.
Maudgal D.P., Kupfer R.M., Northfield T.C. (1983):Gut 24, 1.
Gonzalez-Koch A., Nervi F. (1998):World. Surg. 22, 1145.
Maton P.N., Iser J.H., Reuben A., Saxton H.M., Murphy G.M., Dowling R.H. (1982):Medicine 61, 86.
Bouchier I.A.D. (1988):Gut 29, 137.
Salvioli G., Salati R., Lugli R., Zanni C. (1983):Gut 29, 609.
Ros E., Navarro S., Bru C., Gilabert R., Bianchi L., Bruguera M. (1993):Lancet 342, 404.
Mok H.Y.I., Bell G.D., Dowling R.H. (1974):Lancet 2, 253.
Schoenfield L.J., Lachin J.M. (1981):Annals Intern. Med. 95, 257.
Lanzini A., Facchinetti D., Pigozzi M.G. (1991):Scand. J. Gastroenterol. 26, 551.
Maton P.N., Murphy G.M., Dowling R.H. (1977):Lancet 2, 1297.
Chadwick V.S., Gaginella T.S., Carlson G.L. (1979):J. Lab. Clin. Med. 94, 661.
Bateson M.C., Bouchier I.A.D., Trash D.B. (1981):Br. Med. J. 283, 645.
Villanova N., Bazzoli F., Taroni F., Frabboni R., Mazzella G., Festi D., Barbara L., Roda E. (1989):Gastroenterology 97, 726.
Duan R.D., Erlanson-Albertson C. (1986):Scand. J. Gastroenterol. 21, 1211.
Duan R.D., Erlanson-Albertson C. (1985):Scand. J. Gastroenterol. 20, 1239.
Spraycar M. (ed.) (1995):Stedman’s Medical Dictionary. 26th Edition, Williams and Wilkins, New York.
Takeyama Y., Nakanishi H., Ohyanagi H., Saitoh Y., Kaibuchi K., Takai Y. (1986):J. Clin. Invest. 78, 1604.
Thimister P.W.L., Hopman W.P.M., Tangerman A., Rosenbusch G., Willems H.L., Jansen J.B.M.J. (1998):Hepatology 28, 1454.
Gomez G., Townsend C.M., Green D.W., Rajaraman S., Uchida T., Greeley G.H., Soloway R.D., Thompson J.C. (1990):J. Clin. Invest 86, 323.
Go V.L.W., Brooks F.P., Di Magno E.P., Gardner J.D., Lebenthal E., Scheele G.A. (eds) (1986):The Exocrine Pancreas: Biology, Pathobiology and Diseases. Raven Press, New York.
Holtmann G., Kelly D.G., Sternby B., Di Magno E.P. (1997):Am. J. Physiol.-Gastrointest. Liver Physiol.273, 553.
Vuoristo M., Vaananen H., Miettinen T.A. (1992):Gastroenterology 102, 647.
Wickham M., Garrood M., Leney J., Wilson P.D.G., Fillery-Travis A. (1998):J. Lipid Res. 39, 623.
Amigo L., Mardones P., Ferrada C, Zanlungo S., Nervi F., Miquel J.F., Rigotti A. (2003):Hepatology 38, 727.
Hardcastle J., Hardcastle P., Chapman J., Taylor C. (2001):J. Pharm. Pharmacol. 53, 1457.
Reddy B.S. (1992):Lipids 27, 807.
Ochsenkuhn T., Bayerdorffer E., Meining A., Schinkel M., Thiede C., Nussler V., Sackmann M., Hätz R., Neubauer A., Paumgartner G. (1999):Cancer 85, 1665.
Milovic V., Teller I.C., Faust D., Caspary W.F., Stein J. (2002):Eur. J. Clin. Invest. 32, 29.
Blobe G.C., Obeid L.M., Hannun Y.A. (1994):Cancer Metastasis Rev. 13, 411.
Rao Y.P., Stravitz R.T, Vlahcevic Z.R., Gurley E.C., Sando J.J., Hylemon P.B. (1997):J. Upid Res. 38, 2446.
Im E.O., Choi Y.H., Paik K.J., Suh H., Jin Y., Kim K.W., Yoo Y.H., Kim N.D. (2001):Cancer Lett. 163, 83.
Earnest D.L., Holubec H., Wali R.K., Jolley CS., Bissonette M., Bhattacharyya A.K., Roy H., Khare S., Brasitus T.A. (1994):Cancer Res. 54, 5071.
Suh H., Jung E.J., Kim T.H., Lee H.Y., Park Y.H., Kim K.W. (1991):Cancer Lett., 113, 117.
Choi Y.H., Im E.O., Suh H., Jin Y., Yoo Y.H., Kim N.D. (2003):Cancer Lett. 199, 157.
Kuhajda K., Kevresan S., Mikov M., Sabo A., Miljkovic D. (2000):Arch. Toxicol. Kinet. Xenobiotic Metab. 8, 304.
Mikov M., Kuhajda K., Kandrac J. (2003):Medicinski Pregled 56, 237.
107. De Fabiani E.I., Mitro N., Godio C., Gilardi F., Caruso D., Crestani M. (2004):Biochimie 86, 111.
Li A.C., Glass C.K. (2004):J. Upid Res. 45, 2161.
Miljkovic D., Kuhajda D., Mikov M., Kevresan S., Sabo A. (2000):U. S. Pat. 6, 060, 465.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Mikov, M., Fawcett, J.P., Kuhajda, K. et al. Pharmacology of bile acids and their derivatives: Absorption promoters and therapeutic agents. Eur. J. Drug Metab. Pharmacokinet. 31, 237–251 (2006). https://doi.org/10.1007/BF03190714
Issue Date:
DOI: https://doi.org/10.1007/BF03190714